Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Non-cash Items (2019 - 2025)

Maxcyte (MXCT) has disclosed Non-cash Items for 7 consecutive years, with $11.0 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items rose 29.66% to $11.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.0 million through Dec 2025, up 29.66% year-over-year, with the annual reading at $11.0 million for FY2025, 8.95% up from the prior year.
  • Non-cash Items for Q4 2025 was $11.0 million at Maxcyte, down from $14.4 million in the prior quarter.
  • The five-year high for Non-cash Items was $35.4 million in Q1 2022, with the low at $66547.0 in Q4 2021.
  • Average Non-cash Items over 5 years is $22.5 million, with a median of $23.6 million recorded in 2024.
  • The sharpest move saw Non-cash Items crashed 99.9% in 2021, then soared 35701.76% in 2022.
  • Over 5 years, Non-cash Items stood at $66547.0 in 2021, then skyrocketed by 35701.76% to $23.8 million in 2022, then crashed by 33.46% to $15.9 million in 2023, then crashed by 46.59% to $8.5 million in 2024, then increased by 29.66% to $11.0 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $11.0 million, $14.4 million, and $19.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.